Senior Center Medication Safety and Empowerment Curriculum

• Team Alice Medication Safety and Empowerment Curriculum (MedSEC) (Other): A two-part interactive curriculum that will improve medication safety awareness and empower participants to engage in conversations with healthcare providers. The focus of this study will be to evaluate the impact of the MedSEC on patient/care-partner knowledge and medication management patient activation levels. A pre/post study that surveys older adults/caregivers pre-curriculum intervention and post-curriculum intervention, in addition to 6 months after program completion.

Primary outcomes

• Evaluate the impact of the MedSEC on patient/care-partner knowledge and activation levels in managing medications through the Patient Activation Measure (PAM) [Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.]: Study seeks to enhance patient and care-partner activation, reduce polypharmacy and the use of potentially inappropriate medications (PIMs), and improve shared decision-making through the Patient Activation Measure (PAM).
• Evaluate the impact of the MedSEC on patient/care-partner knowledge and activation levels in managing medications through the Revised Patient Attitudes Towards Deprescribing (rPATD) questionnaires. [Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.]: Study seeks to enhance patient and care-partner activation, reduce polypharmacy and the use of potentially inappropriate medications (PIMs), and improve shared decision-making through the Revised Patient Attitudes Towards Deprescirbing (rPATD) questionnaires.

Secondary outcomes

• Change from Baseline in participant understanding of medication safety risks at 6 Months. [Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.]: 85% of participants will demonstrate an understanding of medication safety risks through pre- and post-program patient/caregiver questionnaires, including the Patient Activation Measure (PAM) and Revised Patient Attitudes to Deprescribing (rPATD). Additional questions pertaining to knowledge retention and actionability will be asked at 6 months.
• Participants will demonstrate knowledge of the 4Ms (Age-Friendly Health System) framework through pre/post/6 month follow up questionnaires. [Change from baseline, post-program assessment (immediately after program completion), and 6 months after program completion.]: By the end of the program, 80% of participants will demonstate knowledge of the 4Ms framework, measured by four questions related to the 4Ms and the Age-Friendly Health System taken prior to the program, immediately post-program, and 6 months after program completion.
• Change in patient engagement as measured by the Patient Activation Measure (PAM) from baseline to 6 months post program. [Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.]: 6 months post-program, 65% of participants will show improved patient engagement, as measured by the Patient Activation Measure (PAM) questionnaire.
• Change from baseline in the mean of medications after 6 months follow-up [Change from baseline and 6 months after program completion.]: Within 6 months of completing program, 50% of participants with polypharmacy will have reduced medication usage by 10%. (mean # of medications.)

Other outcomes

• Post-Survey to Measure Program Impact and Participant Satisfaction [Post curriculum session 2 (immediately after educational session 2, Day 7)]: A post-survey questionnaire (immediately after program completion) will be used to assess the program's educational value and determine its effectiveness in increasing medication safety knowledge, empowerment, and patient self-advocacy, as well as participant satisfaction.

Sex: All, ages: 55 Years to any

Inclusion Criteria:

* 55 years of age and above
* taking prescription medications

Carepartner Inclusion Criteria:

* currently an informal or formal care partner for an eligible patient (regardless of whether they live with or near the patient)
* aged 18 years of age and above

Exclusion Criteria:

* Patients with cognitive impairment that prevents their self-management of medications.